The characteristics and outcomes of critically Ill patients with COVID-19 who received systemic thrombolysis for presumed pulmonary embolism: an observational study

Coronavirus disease 2019 (COVID-19) is associated with abnormal hemostasis, autopsy evidence of systemic microthrombosis, and a high prevalence of venous thromboembolic disease. Tissue plasminogen activator (tPA) has been used in patients with critically ill COVID-19 with high clinical suspicion of...

Descripción completa

Detalles Bibliográficos
Autores principales: So, Matsuo, Steiger, David J., Takahashi, Mai, Egorova, Natalia N., Kuno, Toshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106515/
https://www.ncbi.nlm.nih.gov/pubmed/33966157
http://dx.doi.org/10.1007/s11239-021-02477-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106515/
https://www.ncbi.nlm.nih.gov/pubmed/33966157
http://dx.doi.org/10.1007/s11239-021-02477-5

Ejemplares similares